Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Focal Seizures, Partial Seizures”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Testing effectiveness (Phase 2)Looking for participantsNCT05518578
What this trial is testing

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Who this might be right for
EpilepsySeizures, Epileptic
Supernus Pharmaceuticals, Inc. 60
Post-approval studies (Phase 4)Study completedNCT00160654
What this trial is testing

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Who this might be right for
Epilepsy, Partial
UCB Pharma 251
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Large-scale testing (Phase 3)Study completedNCT00655486
What this trial is testing

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Who this might be right for
Partial EpilepsiesPartial Onset Seizures
UCB BIOSCIENCES, Inc. 97
Not applicableApproved For MarketingNCT04513860
What this trial is testing

Cenobamate Expanded Access Program (EAP)

Who this might be right for
Partial Epilepsy
SK Life Science, Inc.
Large-scale testing (Phase 3)Study completedNCT00957372
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 253
Large-scale testing (Phase 3)Looking for participantsNCT05716100
What this trial is testing

Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

Who this might be right for
Focal Onset Seizures
Xenon Pharmaceuticals Inc. 360
Not applicableWithdrawnNCT03254680
What this trial is testing

Turmeric as Treatment in Epilepsy

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome+2 more
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT05473442
What this trial is testing

Study of EQU-001 for Uncontrolled Focal Onset Seizures

Who this might be right for
Focal Onset Seizures
Equilibre Biopharmaceuticals B.V. 27
Large-scale testing (Phase 3)Ended earlyNCT02134366
What this trial is testing

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Who this might be right for
Epilepsia Partialis ContinuaKojewnikov's EpilepsyEpilepsy
The Cooper Health System 7
Testing effectiveness (Phase 2)Study completedNCT02369471
What this trial is testing

GWP42006 in People With Focal Seizures - Part A

Who this might be right for
EpilepsyFocal Seizures
Jazz Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Not applicableWithdrawnNCT04998123
What this trial is testing

Efficacy of Intersectional Short Pulse Stimulation for Terminating Seizures

Who this might be right for
SeizuresFocal Epilepsy
NYU Langone Health
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Testing effectiveness (Phase 2)Study completedNCT00236691
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Testing effectiveness (Phase 2)Ended earlyNCT03370120
What this trial is testing

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Who this might be right for
Drug-Resistant EpilepsyFocal-Onset Seizures
UCB Biopharma SRL 406
Large-scale testing (Phase 3)Enrolling By InvitationNCT05718817
What this trial is testing

An Open-label Study of XEN1101 in Epilepsy

Who this might be right for
Focal EpilepsyTonic-Clonic Seizures
Xenon Pharmaceuticals Inc. 880
Large-scale testing (Phase 3)Study completedNCT00355082
What this trial is testing

Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline 226
Post-approval studies (Phase 4)Active Not RecruitingNCT06453213
What this trial is testing

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Who this might be right for
Focal Onset Seizure
SK Life Science, Inc. 49
Next Page